231 related articles for article (PubMed ID: 24162170)
1. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study.
Huang ML; Xu XT; Shen J; Qiao YQ; Dai ZH; Ran ZH
J Crohns Colitis; 2014 Apr; 8(4):282-7. PubMed ID: 24067604
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
7. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.
Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF
J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
Rey-Cuille MA; Njouom R; Bekondi C; Seck A; Gody C; Bata P; Garin B; Maylin S; Chartier L; Simon F; Vray M
Pediatr Infect Dis J; 2013 Oct; 32(10):1110-5. PubMed ID: 23694839
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C virus infection in Crohn's disease.
Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
[TBL] [Abstract][Full Text] [Related]
13. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
14. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
15. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
[TBL] [Abstract][Full Text] [Related]
16. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.
Chevaux JB; Nani A; Oussalah A; Venard V; Bensenane M; Belle A; Gueant JL; Bigard MA; Bronowicki JP; Peyrin-Biroulet L
Inflamm Bowel Dis; 2010 Jun; 16(6):916-24. PubMed ID: 19885908
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
20. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]